Protection against septic shock and suppression of tumor necrosis factor α and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 918-924

  Gallily, Ruth ^a   Yamin, Aviva ^a   Waksmann, Yaakov ^a   Ovadia, Haim ^a   Weidenfeld, Joseph ^a   Bar Joseph, Avi ^b   Biegon, Anat ^b   Mechoulam, Raphael ^a   Shohami, Esther ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b PHARMOS LTD   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; DEXANABINOL; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GALACTOSAMINE; GLUCOCORTICOID; MESSENGER RNA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HEAD INJURY; HORMONE RELEASE; HYPOTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ALVEOLUS MACROPHAGE; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MOUSE; NONHUMAN; NORTHERN BLOTTING; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; SEPTIC SHOCK;

ANIMALS; BLOOD PRESSURE; CELL LINE; CORTICOSTERONE; FEMALE; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SHOCK, SEPTIC; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030730585     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. AVRON, A. AND GALLILY, R.: Mycoplasma stimulates the production of oxidative radicals by murine peritoneal macrophages. J. Leukocyte Biol. 57: 264-268, 1995.
2. BAR-JOSEPH, A., BERKOVITCH, Y., ADAMCHIK, J. AND BIEGON, A.: Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils. Mol. Chem. Neuropathol. 23: 125-135, 1994.
3. BASS, R., ENGELHARD, D., TREMBOVLER, V. AND SHOHAMI, E: A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis. J. Infect. Dis. 173: 735-738, 1996.
4. BAUSS, F., DROGE, W. AND MANNEL, D. N.: Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun. 55: 1622-1625, 1987.
5. BELAYEV, L., BUSTO, R., WATSON, B. D. AND GINSBERG, M. D.: Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood brain barrier disruption in photochemical cortical infarction in rats: A quantitative study. Brain Res. 702: 266-270, 1995a.
6. BELAYEV, L., BUSTO, R., ZHAO, W. AND GINSBERG, M. D.: HU-211, a novel non-competitive N-Methyl-D-Aspartate antagonist improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke 26: 2313-2320, 1995b.
7. BENVENISTE, E. N: Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am. J. Physiol. 263: C1-C16, 1992.
8. BEUTLER, B. AND CERAMI, A.: Tumor necrosis, cachexia, shock and inflammation: A common mediator. Annu. Rev. Biochem. 57: 505-518, 1988.
9. BRENNER, T., YAMIN, A., ABRAMSKY, O. AND GALLILY, R.: Stimulation of tumor necrosis factor production by mycoplasmas and inhibition by dexamethasone in cultured astrocytes. Brain Res 608: 273-279, 1993.
10. 9tetrahydrocannabinol. Proc. Soc. Exp. Biol. Med. 209: 205-212, 1995.
11. CHIRGWIN J. M., PRZYBYLA, A. E., MACDONALD, R. J. AND RETTER, W. J.: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18: 5294-5299, 1979.
12. DANTZER, R., GOUJON, E., POUSSET, F. AND PARNET, P.: Regulatory influences of glucocorticoids on cytokine actions in the brain. Presented at the International Society of Psychoneuroendocrinology, XXVIIth Congress, Madrid, Spain. p. 43, August 1996.
13. DOHERTY, G. M., JENSEN, J. C., ALEXANDER, H. R., BURESH, C. M. AND NORTON, J. A.: Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery (St. Louis). 110: 192-198, 1991.
14. ELDRIDGE J. C. AND LANDFIELD, P. W.: Cannabinoid interaction with glucocorticoid receptors in rat hippocampus. Brain Res. 534: 135-141, 1990.
15. ESHHAR, N., STRIEM, S. AND BIEGON, A.: HU-211, a non-psychotropic cannabinoid, rescues cortical neurons from excitatory amino acid toxicity in culture. NeuroReport 5: 237-240, 1993.
16. FEIGENBAUM, J. J., BERGMANN F., RICHMOND, S. A., MECHOULAM, R., NADLER, V., KLOOG, Y. AND SOKOLOVSKY, M: Non-psychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc. Natl. Acad. Sci. U.S.A. 86: 9584-9587, 1989.
17. GLAUSER, M. P., HEUMANN, D., BAUMGARTNER, J. D. AND COHEN, J.: Pathogenesis and potential strategies for prevention and treatment of septic shock: an update. Clin. Infect. Dis. 18: suppl, 2, S205-S216, 1994.
18. HIBBS, J. B., TANTOR, R. AND VAVERIN, Z.: Macrophage cytotoxicity: role for L-arginine deaminase and amino nitrogen oxidation to nitrite. Science 235: 473-476, 1987.
19. 9-Tetrahydrocannabinol, cytokines AND immunity to Legionella pneumophila. Soc. Exp. Biol. Med. 209: 205-212, 1995.
20. LEE, J. C., BADGER, A. M., GRISWOLD, D. E., DUNNINGTON, D., TRUNEH, A., VOTTA, B., WHITE, J. R., YOUNG, P. R. AND BENDER, P. E.: Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann. N.Y. Acad. Sci. 696: 149-170, 1993.
21. LEHMANN, V., FREUDENBERG, M. A. AND GALANOS, C.: Lethal toxicity of lipopoly-saccharide and tumor necrosis factor in normal and D-galactosamine treated mice. J. Exp. Med. 165: 657-663, 1987.
22. MIER J. W., VECHINO, G., NUMERUF, R. P., KOTIK, A. N. AND ATKINS, M. B.: Effects of IL-2 and IL-4 on synthesis of TNF. In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, ed. by B. Beutler, pp. 221-236, Raven Press, New York, 1992.
23. MOREIRA, A. L., SAMPAIO, E. P., ZMUIDZINAS, A., FRINDT, P., SMITH, K. A. AND KAPLAN, G.: Thalidomide exerts its inhibitory action on tumor necrosis factor a by enhancing mRNA degradation J. Exp. Med. 177: 1675-1680, 1993.
24. 45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211. Brain Res. 685: 1-11, 1995.
25. 6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates NMDA receptor-mediated neurotoxicity in primary cultures of rat forebrain. Neurosci. Lett. 162: 43-45, 1993a.
26. 2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211. Brain Res. 622:79-85, 1993b.
27. NOVOGRODSKY, A., VANICHKIN, A., PATYA, M., GAZIT, A., OSHEROV, N. AND LEVITZKI, A.: Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase Inhibitors. Science 264: 1319-1322, 1994.
28. REDDY, M. P., WEBB, E. F., CASSATT, D., MALEY, D., LEE, J. C., GRISWOLD, D. E. AND TRUNEH, A.: Pyridinyl imidazoles inhibit the inflammatory phase of delayed type hypersensitivity reactions without affecting T-dependent immune responses. Int. Immunopharmacol. 16: 795-804, 1994.
29. REMICK, D. G., KUNKEL, R. G., LARRICK, J. W. AND KUNKEL, S. L.: Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest. 56: 583-590, 1987.
30. ROTHWELL, N. J. AND HOPKINS, S. J.: Cytokines and the nervous system II: Action and mechanisms of action. Trends Neurosci. 18: 130-136, 1995.
31. SAWADA, M., KNODO, N., SUZUMURA, A. AND MARUNOUCHI, T.: Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491: 394-397, 1989.
32. SHOHAMI, E., NOVIKOV, M. AND BASS, R.: Long term effect of HU-211, a novel noncompetitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 674: 55-62, 1995.
33. SHOHAMI, E., NOVIKOV, M. AND MECHOULAM, R.: A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. J. Neurotrauma 10: 109-119, 1993.
34. SHOHAMI E., WEIDENFELD J., OVADIA H., VOGEL Z., HANUS L., FRIDE E., BREUER A., BEN-SHABAT S., SHESKIN Z. AND MECHOULAM R.: Endogenous and synthetic cannabinoids: Recent advances. CNS Drug Rev. 2: 429-451, 1996.
35. SHOHAMI, E., GALLILY, R., MECHOULAM, R., BASS, R. AND BEN-HUR, T.: Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNFα inhibitor and an effective neuroprotectant. J. Neuroimmunol. 72: 169-177, 1997.
36. SPANGELO, B. L., JUDD, A. M., MACLEOD, R. M., GOODMAN, D. W. AND ISAKSON, P. C.: Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology 127: 779-1785, 1990.
37. TEALE, D. M. AND ATKINSON, A. M.: Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J. Antimicrob. Chemother. 30: 839-842, 1992.
38. TERASHITA, Z-I., KWAMURA, M., TAKATANI, M., TSUSHIMA, S., IMURA, Y. AND NISHIKAWA, K.: Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J. Pharmacol. Exp. Ther. 260: 748-755, 1992.
39. TRACEY, K. J: Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ. Shock 35: 123-128, 1991.
40. TRACEY, K. J. AND CERAMI, A.: Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45: 491-503, 1994.
41. TRACEY, K. J., BEUTLER, B., LOWRY, S. F., MERRYWEATHER, J., WOLPE, S., MILSARK, I. W., HARIRI, R. J., 3R. D., FAHEY, T. J., ZENTELLA, A., ALBERT, J. D., SHIRES, T. AND CERAMI, A.: Shock and tissue injury induced by recombinant human cachectin. Science 234: 470-474, 1986.
42. WAAGE, A: Presence and involvement of TNF in septic shock. In Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine, ed. by B. Beutler, pp. 275-283, Raven Press, New York, 1992.
43. WATKINS, L. R., MAIER, S. F. AND GOEHLER, L. E.: Minireview: Cytokine-to-brain communication: A review and analysis of alternative mechanisms. Life Sci. 57: 1011-1026, 1995.
44. WEIDENFELD, J., BODOFF, M., SAPHIER, D. AND BRENNER, T.: Further studies on the stimulatory action of nicotine on adrenocortical function in the rat. Neuroendocrinology 50: 132-138, 1989.
45. WOLFE, T. A. AND DASTA, J. F.: Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann. Pharmacol. 29: 36-46, 1995.
46. WOODROOFE, M. N., SARNA, G. S., WADHWA, M., HAYES, G. M., LOUGHLIN, A. J., TINKER, A. AND CUZNER, M. L.: Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: Evidence of a role for microglia in cytokine production. J. Immunol. 33: 227-236, 1991.
47. XU, T., WANG, T. AND HAN, J. S.: Centrally acting endogenous hypotensive substances in rats subjected to endotoxic shock. Life Sci. 51: 1817-1821, 1992.